within Pharmacolibrary.Drugs.ATC.C;

model C08CA01
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.64,
    Cl             = 0.000125,
    adminDuration  = 600,
    adminMass      = 5 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.021,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0009,
    Tlag           = 10.020000000000001,            
    Vdp             = 0.05,
    k12             = 20,
    k21             = 20
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>C08CA01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Amlodipine is a long-acting dihydropyridine calcium channel blocker used primarily for the treatment of hypertension and angina pectoris. It is orally administered and is widely approved and used as first-line therapy for blood pressure control.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after a single oral 5 mg dose.</p><h4>References</h4><ol><li><p>Meredith, PA, &amp; Elliott, HL (1992). Clinical pharmacokinetics of amlodipine. <i>Clinical pharmacokinetics</i> 22(1) 22–31. DOI:<a href=\"https://doi.org/10.2165/00003088-199222010-00003\">10.2165/00003088-199222010-00003</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/1532771/\">https://pubmed.ncbi.nlm.nih.gov/1532771</a></p></li><li><p>Abernethy, DR (1992). Pharmacokinetics and pharmacodynamics of amlodipine. <i>Cardiology</i> 80 Suppl 1 31–36. DOI:<a href=\"https://doi.org/10.1159/000175050\">10.1159/000175050</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/1534713/\">https://pubmed.ncbi.nlm.nih.gov/1534713</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end C08CA01;
